Atrás
Rango del Día
$177.84
$178.80
Rango de 52 Semanas
$125.94
$178.87
Volumen
1,587,309
Promedio 50D / 200D
$155.89
/
$150.88
Cierre Anterior
$178.44
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -63.4 | 0.3 |
| P/B | 13.3 | 2.9 |
| ROE % | -17.1 | 3.7 |
| Net Margin % | -9.9 | 3.8 |
| Rev Growth 5Y % | 5.4 | 10.0 |
| D/E | 0.8 | 0.2 |
Precio Objetivo de Analistas
Hold
$187.50
+4.9%
Low: $180.00
High: $200.00
P/E Futuro
32.5
EPS Futuro
$5.50
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
1.5 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$7.43
$7.37 – $7.49
|
2 B | 1 |
| FY2029 |
$7.43
$7.37 – $7.49
|
1.9 B | 1 |
| FY2028 |
$6.66
$6.37 – $7.18
|
1.7 B | 6 |
Puntos Clave
Revenue grew 5.36% annually over 5 years — modest growth
Generating 197.80M in free cash flow
PEG of 0.89 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 32.46%
Capital efficient — spends only 1.27% of revenue on capex
ROIC of 18.32% — excellent capital efficiency
Crecimiento
Revenue Growth (5Y)
5.36%
Revenue (1Y)-27.10%
Earnings (1Y)N/A
FCF Growth (3Y)455.93%
Calidad
Return on Equity
-17.09%
ROIC18.32%
Net Margin-9.92%
Op. Margin20.49%
Seguridad
Debt / Equity
0.78
Current Ratio2.49
Interest Coverage9.42
Valoración
P/E Ratio
-63.35
P/B Ratio13.31
EV/EBITDA31.99
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -27.10% | Revenue Growth (3Y) | -13.66% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 5.36% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.53B | Net Income (TTM) | -151.50M |
| ROE | -17.09% | ROA | -8.92% |
| Gross Margin | 61.90% | Operating Margin | 20.49% |
| Net Margin | -9.92% | Free Cash Flow (TTM) | 197.80M |
| ROIC | 18.32% | FCF Growth (3Y) | 455.93% |
| Safety | |||
| Debt / Equity | 0.78 | Current Ratio | 2.49 |
| Interest Coverage | 9.42 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -63.35 | P/B Ratio | 13.31 |
| P/S Ratio | 6.29 | PEG Ratio | 0.89 |
| EV/EBITDA | 31.99 | Dividend Yield | 0.00% |
| Market Cap | 9.60B | Enterprise Value | 10.01B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.53B | 2.09B | 2.05B | 2.04B | 1.24B |
| Net Income | -151.50M | -304.90M | 81.50M | 143.50M | 229.60M |
| EPS (Diluted) | -2.80 | -5.72 | 1.51 | 2.60 | 3.98 |
| Gross Profit | 945.20M | 1.00B | 1.00B | 1.06B | 808.40M |
| Operating Income | 312.80M | -266.70M | 136.50M | 210.00M | 275.80M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.70B | 2.63B | 3.04B | 3.21B | 1.89B |
| Total Liabilities | 977.70M | 1.57B | 1.68B | 1.87B | 336.80M |
| Shareholders' Equity | 721.20M | 1.05B | 1.36B | 1.34B | 1.55B |
| Total Debt | 559.30M | 846.10M | 970.00M | 1.03B | 32.70M |
| Cash & Equivalents | 152.30M | 177.60M | 163.00M | 202.90M | 745.30M |
| Current Assets | 926.00M | 1.23B | 1.23B | 1.31B | 1.24B |
| Current Liabilities | 371.60M | 617.70M | 563.80M | 630.00M | 267.70M |